Tempest Therapeutics, Inc. TPST NASDAQ

Tempest Therapeutics, Inc. (TPST) reported total assets of $16.93M and total liabilities of $10.26M for quarter ending 2025-12-31, resulting in total equity of $6.67M.

The company held $7.71M in cash and short-term investments. Total debt stood at $8.14M, with net debt of $434K. The Debt-to-Equity (D/E) ratio was 1.22 (moderate).

Current ratio is 2.5, indicating strong short-term liquidity.

Criteria supported by this page:

• HEALTH (50/100, Partial) — some metrics are adequate but not all reach ideal thresholds
• MOAT (28/100) — Total assets $16.93M and equity $6.67M support the company's competitive scale
• VALUE (100/100) — Debt-to-Equity 1.22 contributes to the overall valuation risk assessment

Overall SharesGrow Score: 51/100 with 2/7 criteria passed.